Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Theratechnologies (TH.TO)

Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 81,385
  • Shares Outstanding, K 45,980
  • Annual Sales, $ 81,764 K
  • Annual Income, $ -23,957 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.13
  • Price/Sales 0.69
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $0.06 on 10/10/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 11/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +908,281.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.62 +12.35%
on 10/09/24
1.94 -6.19%
on 10/21/24
+0.12 (+7.06%)
since 10/07/24
3-Month
1.59 +14.47%
on 10/03/24
1.95 -6.67%
on 09/16/24
+0.02 (+1.11%)
since 08/07/24
52-Week
1.50 +21.33%
on 11/13/23
3.43 -46.94%
on 01/08/24
+0.12 (+7.06%)
since 11/07/23

Most Recent Stories

More News
Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV

HDL : 17.43 (+4.43%)
TH.TO : 1.82 (+2.82%)
THTX : 1.3100 (+2.34%)
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

TH.TO : 1.82 (+2.82%)
THTX : 1.3100 (+2.34%)
Theratechnologies: Fiscal Q3 Earnings Snapshot

Theratechnologies: Fiscal Q3 Earnings Snapshot

TH.TO : 1.82 (+2.82%)
Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024

TH.TO : 1.82 (+2.82%)
THTX : 1.3100 (+2.34%)
Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV

TH.TO : 1.82 (+2.82%)
THTX : 1.3100 (+2.34%)
Stocks in play: Theratechnologies Inc.

Announced that CEO Paul Lévesque will be presenting at two investor conferences in September. Members ...

TH.TO : 1.82 (+2.82%)
Theratechnologies: Fiscal Q2 Earnings Snapshot

Theratechnologies: Fiscal Q2 Earnings Snapshot

TH.TO : 1.82 (+2.82%)
Theratechnologies: Fiscal Q1 Earnings Snapshot

Theratechnologies: Fiscal Q1 Earnings Snapshot

TH.TO : 1.82 (+2.82%)
Stocks in play: Theratechnologies Inc.

Today announced two posters will be presented at the American Association for Cancer Research (AACR) ...

TH.TO : 1.82 (+2.82%)
Theratechnologies: Fiscal Q4 Earnings Snapshot

Theratechnologies: Fiscal Q4 Earnings Snapshot

TH.TO : 1.82 (+2.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization...

See More

Key Turning Points

3rd Resistance Point 1.95
2nd Resistance Point 1.89
1st Resistance Point 1.85
Last Price 1.82
1st Support Level 1.75
2nd Support Level 1.69
3rd Support Level 1.65

See More

52-Week High 3.43
Fibonacci 61.8% 2.69
Fibonacci 50% 2.47
Fibonacci 38.2% 2.24
Last Price 1.82
52-Week Low 1.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar